Literature DB >> 33421065

TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP.

Isidro Ferrer1,2,3,4,5, Pol Andrés-Benito1,2,3,4, Margarita Carmona1,2,3, Abdelilah Assialioui6, Mónica Povedano6,7.   

Abstract

Sporadic amyotrophic lateral sclerosis (sALS) and FTLD-TDP are neurodegenerative diseases within the spectrum of TDP-43 proteinopathies. Since abnormal blood vessels and altered blood-brain barrier have been described in sALS, we wanted to know whether TDP-43 pathology also occurs in blood vessels in sALS/FTLD-TDP. TDP-43 deposits were identified in association with small blood vessels of the spinal cord in 7 of 14 cases of sALS and in small blood vessels of frontal cortex area 8 in 6 of 11 FTLD-TDP and sALS cases, one of them carrying a GRN mutation. This was achieved using single and double-labeling immunohistochemistry, and double-labeling immunofluorescence and confocal microscopy. In the sALS spinal cord, P-TDP43 Ser403-404 deposits were elongated and parallel to the lumen, whereas others were granular, seldom forming clusters. In the frontal cortex, the inclusions were granular, or elongated and parallel to the lumen, or forming small globules within or in the external surface of the blood vessel wall. Other deposits were localized in the perivascular space. The present findings are in line with previous observations of TDP-43 vasculopathy in a subset of FTLD-TDP cases and identify this pathology in the spinal cord and frontal cortex in a subset of cases within the sALS/FTLD-TDP spectrum.
© 2021 American Association of Neuropathologists, Inc.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Blood vessels; Endothelial cells; Frontotemporal lobar degeneration; Pericytes; TDP-43

Mesh:

Substances:

Year:  2021        PMID: 33421065      PMCID: PMC7899266          DOI: 10.1093/jnen/nlaa162

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  80 in total

1.  Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis.

Authors:  Shoichi Sasaki
Journal:  Neuropathology       Date:  2015-08-04       Impact factor: 1.906

2.  TARDBP mutation p.Ile383Val associated with semantic dementia and complex proteinopathy.

Authors:  E Gelpi; J van der Zee; A Turon Estrada; C Van Broeckhoven; R Sanchez-Valle
Journal:  Neuropathol Appl Neurobiol       Date:  2014-02       Impact factor: 8.090

3.  ALS skin fibroblasts reveal oxidative stress and ERK1/2-mediated cytoplasmic localization of TDP-43.

Authors:  Nicla Romano; Alessia Catalani; Serena Lattante; Antonio Belardo; Silvia Proietti; Laura Bertini; Federica Silvestri; Elisabetta Catalani; Davide Cervia; Lello Zolla; Mario Sabatelli; Kristy Welshhans; Marcello Ceci
Journal:  Cell Signal       Date:  2020-02-29       Impact factor: 4.315

4.  Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth.

Authors:  Bettina Schmid; Alexander Hruscha; Sebastian Hogl; Julia Banzhaf-Strathmann; Katrin Strecker; Julie van der Zee; Mathias Teucke; Stefan Eimer; Jan Hegermann; Maike Kittelmann; Elisabeth Kremmer; Marc Cruts; Barbara Solchenberger; Laura Hasenkamp; Frauke van Bebber; Christine Van Broeckhoven; Dieter Edbauer; Stefan F Lichtenthaler; Christian Haass
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-01       Impact factor: 11.205

5.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

6.  TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy.

Authors:  Michael A Gitcho; Eileen H Bigio; Manjari Mishra; Nancy Johnson; Sandra Weintraub; Marsel Mesulam; Rosa Rademakers; Sumi Chakraverty; Carlos Cruchaga; John C Morris; Alison M Goate; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2009-07-18       Impact factor: 17.088

Review 7.  Motor neuron disease and frontotemporal lobar degeneration: a tale of two disorders linked to TDP-43.

Authors:  Lauren B Elman; Leo McCluskey; Murray Grossman
Journal:  Neurosignals       Date:  2007-12-05

8.  TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis.

Authors:  Maria Teresa Giordana; Marco Piccinini; Silvia Grifoni; Giovanni De Marco; Marco Vercellino; Michela Magistrello; Alessia Pellerino; Barbara Buccinnà; Elisa Lupino; Maria Teresa Rinaudo
Journal:  Brain Pathol       Date:  2009-03-17       Impact factor: 6.508

9.  Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation.

Authors:  Michael C Chang; Karpagam Srinivasan; Brad A Friedman; Eric Suto; Zora Modrusan; Wyne P Lee; Joshua S Kaminker; David V Hansen; Morgan Sheng
Journal:  J Exp Med       Date:  2017-08-04       Impact factor: 14.307

10.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.

Authors:  Ian R A Mackenzie; Atik Baborie; Stuart Pickering-Brown; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; David Neary; Julie S Snowden; David M A Mann
Journal:  Acta Neuropathol       Date:  2006-09-26       Impact factor: 17.088

View more
  2 in total

1.  Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS.

Authors:  Sarah Waters; Molly E V Swanson; Birger V Dieriks; Yibin B Zhang; Natasha L Grimsey; Helen C Murray; Clinton Turner; Henry J Waldvogel; Richard L M Faull; Jiyan An; Robert Bowser; Maurice A Curtis; Mike Dragunow; Emma Scotter
Journal:  Acta Neuropathol Commun       Date:  2021-08-26       Impact factor: 7.801

2.  Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis.

Authors:  Ario Mirian; Alexander Moszczynski; Serena Soleimani; Isabelle Aubert; Lorne Zinman; Agessandro Abrahao
Journal:  Front Cell Neurosci       Date:  2022-03-31       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.